Companies / Hepatx
Hepatx
Palo Alto, United States
HepaTx develops new treatments for liver disease using regenerative medicine technologies and stem cells as an alternative to liver transplant.
Hepatx, based in Palo Alto, United States, has 5 investors on file, among them Argonautic Ventures, iSelect Fund and Natural Bridge Ventures. Its site was last checked 12 Nov 2026: site answers.
Investors
5 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Corporate VC | |
| Portfolio page | Accelerator | |
| Portfolio page | Accelerator |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Hepatx and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Argonautic Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/hepatx.com/investors
# also
GET /v1/companies/hepatx.com
GET /v1/companies/hepatx.com/news